IP Library Granted Patent US 7,576,118
Granted Patent B2
US 7,576,118 · App. 11/097,565 · Granted Aug 18, 2009

Asymmetric hydrogenation process

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,576,118
App. No.
11/097,565
Granted
Aug 18, 2009
Kind
B2
Abstract

The present invention provides an asymmetric hydrogenation process for the preparation of chiral cycloalkanoindole DP receptor antagonists in high enantiomeric excess.

Claims (24)

1. An asymmetric hydrogenation process for the preparation of a compound of formula I or a salt thereof in at least 50% enantiomeric excess (ee)

wherein n is 1 or 2, R 1 is Br or SO 2 CH 3 , and R 2 is H, benzyl, 4-nitrobenzyl, 4-aminobenzyl, 4-trifluoromethylbenzyl or 4-chlorobenzyl, which comprises: treating a compound of formula II or a salt thereof

with a metal-chiral ligand and a hydrogen donor wherein when the hydrogen donor is H 2 , the process is carried out at a pressure of from about 0 to about 500 pounds per square inch gauge (psig), and wherein said metal-chiral ligand is (a) a ruthenium-axially chiral phosphine ligand complex, or (2) a rhodium chiral ferrocenyl phosphine ligand complex, or (3) a rhodium-TMBTP complex.

2. The process of claim 1 wherein said metal-chiral ligand is ruthenium-axially chiral phosphine ligand complex and said chiral ligand is selected from BINAP (formula (a) Ar=phenyl), tol-BINAP (formula (a) Ar=p-tolyl), xyl-BINAP (formula (a) Ar=3,5-xylyl), H8-BINAP (formula (b) Ar=phenyl), SYNPHOS™ (formula (c) Ar=phenyl), SEGPHOS (formula (d) Ar=phenyl), Solvias BINAP (formula (e) Ar=phenyl), SOLVIAS xyl-BINAP (formula (e) Ar3,5-xylyl), MeO-BIPHEP (formula (f) Ar=phenyl, Z=methyl, R a =R b =R c =H), hexaPHEMP (formula (f) Ar=phenyl, Z=R a =R b =methyl, R c =H), tunaphos (formula (g) Ar=phenyl and n is 1-6), TMBTP (formula (h) Ar=phenyl), P-Phos (formula (i) Ar=phenyl), tol-P-Phos (formula (i) Ar=tolyl), xyl-P-Phos (formula (i) Ar=3,5-xylyl),

3. The process of claim 1 wherein said metal-chiral ligand is (p-cymene)Ru(S)-BINAP-Cl 2 .

4. The process of claim 1 wherein said metal-chiral ligand is (chiral ligand)RuX 2 , wherein each occurrence of X is independently selected from Cl, Br, I, triflate, acetate, methanesulfonate, benzenesulfonate, BF 4 , and B(Ar) 4 , and Ar is phenyl, m- or p-toyl, xylyl and methoxyphenyl.

5. The process of claim 1 wherein said metal-chiral ligand is a rhodium-ferrocenyiphosphine ligand complex and said ferrocenyiphosphine ligand is selected from f-BINAPHANE of formula (m)

Walphos (formula (j) wherein R d and R e are each methyl or trifluoromethyl)

the josiphos of formula (k)

the taniaphos of formula (l)

6. The process of claim 1 wherein said metal-chiral ligand is a rhodium-TMBTP complex.

7. The process of claim 1 wherein said hydrogenation is carried out in the presence of a base and optionally in the presence of a Group I or Group II salt.

8. An asymmetric hydrogenation process for the preparation of a compound of formula Ia or a salt thereof in at least 50% enantiomeric excess (ee)

which comprises: treating a compound of formula IIa or a salt thereof

with a metal-chiral ligand and a hydrogen donor wherein when the hydrogen donor is H 2 , the process is carried out at a pressure of from about 0 to about 500 pounds per square inch gauge (psig), and wherein said metal-chiral ligand is (a) a ruthenium-axially chiral phosphine ligand complex, or (2) a rhodium chiral ferrocenyl phosphine ligand complex, or (3) a rhodium-TMBTP complex.

9. The process of claim 8 wherein said hydrogenation is carried out with hydrogen in the presence of a base, and wherein said metal-chiral ligand is selected from (1) ruthenium complex with BINAP (formula (a) Ar=phenyl), tol-BINAP (formula (a) Ar=-tolyl), xyl-BINAP (formula (a) Ar=3,5-xylyl), H 8 -BINAP (formula (b) Ar=phenyl), SYNPHOS™ (formula (c) Ar=phenyl), SEGPHOS (formula (d) Ar=phenyl), Solvias BINAP (formula (e) Ar=phenyl), SOLVIAS xyl-BINAP (formula (e) Ar3,5-xylyl), MeO-BIPHEP (formula (f) Ar=phenyl, Z=methyl, R a =R b =R c H), hexaPHEMP (formula (f) Ar=phenyl, Z=R a =R b =methyl, R c =H), tunaphos (formula (g) Ar=phenyl and n is 1-6), TMBTP (formula (h) Ar=phenyl), P-Phos (formula (i) Ar=phenyl), tol-P-Phos (formula (i) Ar=tolyl), xyl-P-Phos (formula (i) Ar3,5-xylyl)

(2) rhodium complex with from f-BINAPHANE of formula (m)

Walphos (formula (i) wherein R d and R e are each methyl or trifluoromethyl)

the josiphos of formula (k)

the taniaphos of formula (l)

10. The process of claim 8 wherein said hydrogenation is carried out at a pressure of from about 0 to about 20 psig.

11. A compound of the formula II or a salt thereof:

wherein n, R 1 and R 2 are as defined in claim 1 .

12. The compound of claim 11 or a salt thereof, wherein n is 1, R 1 is —SO 2 CH 3 , and R 2 is 4-chlorobenzyl.

Assignments (3)
CHANGE OF NAME Recorded Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
MERGER Recorded Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
CHANGE OF NAME Recorded Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023870/0001 →